The hydroxypyridones: A class of antimycotics of its own

Mycoses

Volumn 40, Issue 7-8, 1997, Pages 243-247

  Korting, H C ^a,b   Grundmann Kollmann, M ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Ciclopirox (free acid); Ciclopirox olamine; Hydroxypyridones; Rilopirox

Indexed keywords

ANTIFUNGAL AGENT; CICLOPIROX; CICLOPIROXOLAMINE; RILOPIROX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; CANDIDIASIS; CONTROLLED STUDY; DERMATOMYCOSIS; DERMATOPHYTE; DOG; FUNGUS; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MYCOSIS; NONHUMAN; ONYCHOMYCOSIS; PITYRIASIS; PRIORITY JOURNAL; RABBIT; REVIEW; TOPICAL DRUG ADMINISTRATION;

EID: 0031456299     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0507.1997.tb00227.x     Document Type: Review

References (34)

1. Dittmar, W., Grau, W., Raether, W., Schrinner, W. & Wagner, W. H. (1981) Mikrobiologische Laboruntersuchungen mit Ciclopiroxolamin. Arzneim. Forsch. 31, 1317-1322.
2. Hoffman, B. D. (1991) A new class of reversible cell cycle inhibitors. Cytometry 12, 26-32.
3. Reitze, N. (1993) Ultrastructural investigations of Candida albicans after in vitro treatment with the new fungicidal agent rilopirox. mycoses 36, 385-395.
4. Sakurai, K., Sakaguchi, T., Yamaguchi, H. & Iwata, K. (1978) Studies on uptake of 6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone ethanolamine salt (Hoe 296) by Candida albicans. Chemotherapy 24, 146-153.
5. Del Palacio Hernandez, N. (1990) Changes in fungal ultrastructure after short-course ciclopiroxolamine therapy in pityriasis versicolor. Clin. Exp. Dermatol. 15, 95-100.
6. Gasparini, G. (1986) The effect of ciclopiroxolamine investigated by methods of the freeze fracture technique. mykosen 29, 539-544.
7. Dittmar, W. (1980) Pyridones. Medical Mycology, Zbl. Bakt. Suppl. 8, Gustav Fischer Verlag, Stuttgart, New York.
8. Räther, W., Hänel, H. (1990) Rilopirox - a new hydroxypyridone antifungal with fungicidal properties. mycoses 33, 191-202.
9. Mac Kerrow, S. D., Merry, J. M., Hoeprich, P. D. (1991) Effects of buffers on testing of Candida species susceptibility to flucytosine. J. Clin. Microbiol. 25, 885-888.
10. Dittmar, W. (1975) Contribution to the methodology of testing topical antimycotic agents in guinea pig dermatophytoses. mykosen 18, 351-361.
11. Hänel, H., Abrams, B., Dittmar, W. & Ehlers, G. (1988) A comparison of Bifonazole and Ciclopiroxolamine: in vitro, animal and clinical studies. mycoses 31, 632-640.
12. Hänel, H. (1988) Evaluation of fungicidal action in vitro and in a skin model considering the influence of penetration kinetics of various standard antimycotics. Ann. N. Y. Acad. Sci. 544, 327-329.
13. Manzardo, S., Pinzetta, A., Coppi, G. (1993) Local tolerance of a new ciclopirox olamine vaginal preparation in rats and rabbits. J. Chemother. 5, 307-311.
14. Braga, P. C., Piatti, G., Conti, E. & Vignali, F. (1992) Effects of subinhibitory concentrations of ciclopirox on the adherence of Candida albicans to human buccal and vaginal epithelial cells. Arzneim. Forsch. 42, 1368-1371.
15. Braga, P. C., Maci, S., Dal Sasso, M. & Bohn, M. (1995) Inhibition of Candida albicans adhesiveness to human buccal and vaginal cells by sub-inhibitory concentrations of rilopirox. Arzneim. Forsch. 45, 84-87.
16. Alpermann, H. G., Schütz, E. (1981) Zur Pharmakologie und Toxikologie von Ciclopiroxolamin. Arzneim. Forsch. 31, 1328.
17. Sakurai, K., Sakaguchi, T., Yamaguchi, H. & Iwata, K. (1975) In vitro and in vivo antimicrobial activity of HOE 296. Jap. J. Med. Mycol. 16, 35-40.
18. Miyamoto, M. (1975) Teratological studies of 6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone ethanolamine salt (HOE 296) in mice and rats. Pharmacometrics (Tokyo) 9, 67-81.
19. Deichmann, B. (1986) Behandlung von Dermatomykosen mit einem Lokalantimykotikum. Therapiewoche 36, 512-518.
20. Torres, J., Savopoulos, Ch. & Dittmar, W. (1981) Offene Prüfung einer lprozentigen Ciclopiroxolamin-Lösung auf Polyethylenglykol 400 Basis bei Dermatomykosen in der Bundesrepublik Deutschland. Studie mit verkürzter Therapiedauer. Arzneim. Forsch. 31, 1373-1376.
21. Peil, H. G. (1981) Offene Studie zur Wirksamkeit und Verträglichkeit von Ciclopiroxolamin bei vulvovaginaler Candidose. Arzneim. Forsch. 31, 1366.
22. Bagatell, F. K. (1985) Evaluation of a new antifungal cream, ciclopirox olamine 1% in the treatment of cutaneous candidosis. Clin. Ther. 8, 41-48.
23. Corte, M., Jung, K., Linker, U., Martini, H., Sapp-Boncelet, I. & Schulz, H. (1987) Topische Anwendung einer 1%igen Ciclopiroxolamin Lösung zur Behandlung der Pityriasis versicolor. mycoses 32, 200-203.
24. Sayegh-Carreno, R., Abramovits-Ackermann, W. & Giron, G. P. (1989) Therapy of Tinea nigra plantaris. Int. J. Dermatol. 28, 46-48.
25. Haufe, U. (1988) Ciclopiroxolamin bei Erythrasma: GIT Suppl. 6, 30-32.
26. Stary, H., Rüping, K. W., Schulz, H., Tronnier, H. & Herz, G. (1990) Ciclopiroxolamin zur topischen Behandlung von Dermatomykosen der Säuglinge und Kleinkinder. hautnah Päd 6, 38-44.
27. Lo Scocco, G. (1986) Terapia della onicomicosi con ciclopiroxolamina per uso topico. Dermatol. Clin. 6, 256-260.
28. Wieczorek, M. (1990) Biphasische Onychomykose-Therapie mit Ciclopiroxolamin. hautnah Derm 6, 43-52.
29. Wu, Y. G., Chuan, M. T., Lü, Y. C. (1991) Efficacy of ciclopiroxolamine cream 1% in onychomycosis and tinea pedis. mycoses 34, 93-95.
30. Angelini, G., Barile, F., Meneghine, C. L. (1985) La ciclopiroxolamina nella terapia delle dermatomicosi. Atti. 21 Congr. Soc. It. Microbiologica Roma 6, 12.
31. Goitre, M., Bedello, P. G., Cane, D., Pulatti, P., Forte, M. & Cervetti, O. (1986) Contact dermatitis due to ciclopiroxolamine. Contact Dermatitis 15, 94-95.
32. Korting, H. C., Ollert, M., Abeck, D. & German Collaborative Dermatophyte Drug Susceptibility Study Group (1995) Results of German multicenter study of antimicrobial susceptibilities of Trichophyton rubrum and Trichophyton mentagrophytes. Antimicrob. Agents Chemother. 39, 1206-1208.
33. Nolting, S. & Seebacher, C. (1993) Ciclopiroxolamin: Wegweiser topischer Mykose-Therapie. Universitäts-verlag Jena.
34. Drake, L. A., Dinehart, S. M., Farmer, E. R., Goltz, R., Graham, G. F., Hordinski, M. K. et al. (1996) Guidelines for care of superficial mycotic infections of the skin: Onychomycosis. J. Am. Acad. Dermatol. 34, 116-121.